No long-term excess mortality after measles infection: A community study from Senegal

American Journal of Epidemiology

Volumn 143, Issue 10, 1996, Pages 1035-1041

  Aaby, Peter ^a,b   Samb, Badara ^a   Andersen, Marc ^c   Simondon, Francois ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

immunization; infection; measles

Indexed keywords

ARTICLE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PRESCHOOL CHILD; RISK ASSESSMENT; RURAL POPULATION; SCHOOL CHILD; SENEGAL;

CHILD MORTALITY; IMMUNISATION; MEASLES;

SENEGAL;

EID: 0029669863     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008667     Document Type: Article

References (28)

1. Hull HF, Williams PJ, Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet 1983;1:972-5.
2. Aaby P, Bukh J, Lisse IM, et al. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984;8:13-21.
3. Aaby P, Clements J. Measles immunization research. A review. Bull WHO 1989;67:443-8.
4. Aaby P, Knudsen K, Jensen TG, et al. Measles incidence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. J Infect Dis 1990;162:1043-8.
5. The Kasongo Project Team. Influence of measles vaccination on survival pattern of 7-35-month-old children in Kasongo, Zaire. Lancet 1981;1:764-7.
6. Aaby P, Samb B, Simondon F, et al. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. Am J Epidemiol 1993;138:746-55.
7. Clemens JD, Stanton BF, Chakraborty J, et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988;128:1330-9.
8. Holt EA, Boulos R, Halsey NA, et al. Childhood survival in Haiti: protective effect of measles vaccination. Pediatrics 1990;85:188-94.
9. Aaby P, Knudsen K, Whittle H, et al. Long-term survival after Edmonston-Zagreb measles vaccination: increased female mortality. J Pediatr 1993;122:904-8.
10. Holt EA, Moulton LH, Siberry GK, et al. Differential mortality by measles vaccine titer and sex. J Infect Dis 1993;168: 1087-96.
11. Leon ME, Ward B, Kanashiro R, et al. Immunologie parameters 2 years after high-titer measles immunization in Peruvian children. J Infect Dis 1993;168:1097-1104.
12. Whittle HC, Campbell H, Rahman S, et al. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine. Lancet 1990;336:1046-8.
13. Halsey N. Increased mortality following high titer measles vaccines: too much of a good thing. J Pediatr Infect Dis 1993;12:462-5.
14. Garenne M, Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis 1990;161:1088-94.
15. Aaby P. Influence of cross-sex transmission on measles mortalily in rural Senegal. Lancet 1992;340:388-91.
16. Garenne M. Variations in the age pattern of infant and child mortality with special reference to a case study in Ngayokheme (rural Senegal). PhD thesis. Philadelphia: University of Pennsylvania, 1982.
17. Samb B, Aaby P, Whittle H, et al. Serological status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 1995;14:203-9.
18. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
19. Aaby P, Bukh J, Hoff G, et al. High measles mortality in infancy related to intensity of exposure. J Pediatr 1986; 109: 40-4.
20. Chen RT, Weierbach R, Bisoffi Z, et al. A "post-honeymoon period" measles outbreak in Muyinga Sector, Burundi. Int J Epidemiol 1994;23:185-93.
21. Lange PK. Morbilli and tuberculosis in Greenland. Scand J Respir Dis 1970;51:256-67.
22. Petralli JK, Merigan TC, Wilbur JR. Action of endogenous interferon against vaccinia infection in children. Lancet 1965; 2:401-5.
23. Rooth I, Sinani HM, Smedman L, et al. A study of malaria infection during the acute stage of measles infection. J Trop Med Hyg 1991;94:195-8.
24. Aaby P, Andersen M, Sodemann M, et al. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. BMJ 1993;307:1308-11.
25. Aaby P, Samb B, Simondon F, et al. Non-specific beneficial effect of measles immunization. Analysis of mortality studies from developing countries. BMJ 1995;311:481-5.
26. Lisse IM, Aaby P, Whittle H, et al. Long-term impact of high-titer Edmonston-Zagreb measles vaccine on T-cell subsets. Pediatr Infect Dis J 1994;13:109-12.
27. Desgrées du Loû A, Pison G, Aaby P. Role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. Am J Epidemiol 1995;142:643-52.
28. Hall A, Aaby P. Tropical trials and tribulations. Int J Epidemiol 1990;19:777-81.